Ed Doo, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
13
0
7
N/A
0
17
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (13)
Showing 10 of 13 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Averell Sherker, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
Katrina Loh, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Worked with same sponsors:
Lisa Henn, PhD
Arbor Research Collaborative for Health
Shared therapeutic areas:
Worked with same sponsors:
John Magee, MD
University of Michigan Medical Center, Ann Arbor
Shared therapeutic areas:
Worked with same sponsors:
Lisa Henn, PhD
Arbor Research Collaborative for Health - Data Coordinating Center
Shared therapeutic areas:
Worked with same sponsors:
John C Magee, MD
University of Michigan
Shared therapeutic areas:
Worked with same sponsors:
Lisa Henn, PhD
Arbor Research Collaborative of Health
Shared therapeutic areas:
Worked with same sponsors:
Benjamin Shneider, MD
Baylor College of Medicine
Shared therapeutic areas:
Worked with same sponsors:
John Magee, MD
University of Michigan
Shared therapeutic areas:
Worked with same sponsors:
Valerie L Durkalski-Mauldin, PhD
Medical University of South Carolina
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (13)
Showing 13 of 13 trials
TReatment for ImmUne Mediated PathopHysiology
Primary Sclerosing Cholangitis in Children
Longitudinal Assessment of Transient Elastography in Cystic Fibrosis
MRI to Characterize and Predict CF Liver Disease in PUSH Cohort
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Longitudinal Study of Mitochondrial Hepatopathies
Prediction by Ultrasound of the Risk of Hepatic Cirrhosis in Cystic Fibrosis
Longitudinal Study of Genetic Causes of Intrahepatic Cholestasis (LOGIC)
Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
All 13 trials loaded